Former Novo CEO Lars Rebien appointed executive chair at Ferring

Lars Rebien Sørensen, the former long-standing CEO of Novo Nordisk, joined Ferring Pharmaceuticals as chair of the board in summer last year, and has now been appointed its executive chair, an amalgamation of a chief executive and chair position, although he retains most of his chair duties. The news comes with a record-breaking annual report from the company.
Chair of the Novo Nordisk Foundation, Lars Rebien Sørensen, has been appointed executive chair at pharmaceutical firm Ferring Pharmaceuticals | Photo: Finn Frandsen/Politiken/Ritzau Scanpix
Chair of the Novo Nordisk Foundation, Lars Rebien Sørensen, has been appointed executive chair at pharmaceutical firm Ferring Pharmaceuticals | Photo: Finn Frandsen/Politiken/Ritzau Scanpix
by albert rønning-andersson, translated by daniel pedersen

The chair of the Novo Nordisk Foundation, Lars Rebien Sørensen, who stood at the helm of Novo Nordisk for many years, has been appointed Executive Chairman at Ferring Pharmaceuticals, a company press release has announced.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading